Three repeated intrathecal injections of allogenic umbilical cord-derived mesenchymal stromal cells in autism spectrum disorder: a Phase I clinical trial.
Stem cell research & therapy · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansAutism Spectrum DisorderMaleChild, PreschoolChildFemaleMesenchymal Stem CellsMesenchymal Stem Cell TransplantationInjections, SpinalUmbilical CordTransplantation, HomologousAutism spectrum disorderCell therapyMesenchymal stromal cellsRegenerative medicine
Come citare questo studio
Elaheh Khodadoust, Hadi Zarafshan, Masoumeh Nouri, Anahita Majmaa, Ali Khaleghi, Fatemeh Zamani, Milad Seyfi, Mohammad Amin Shahrbaf, Solaleh Samimi, Bahareh Sadri, Seyedeh Malihe Mahmoodi, Norouz Abdi, Ali Ghasemi, Mahmoud Reza Ashrafi, Morteza Zarrabi, Massoud Vosough, Mohammad Reza Mohammadi. (2026). Three repeated intrathecal injections of allogenic umbilical cord-derived mesenchymal stromal cells in autism spectrum disorder: a Phase I clinical trial.. Stem cell research & therapy. DOI: 10.1186/s13287-026-05122-1
Consulta la pubblicazione originale ↗